InVivo Therapeutics Holdings Debt to Equity Ratio 2010-2023 | NVIVQ
InVivo Therapeutics Holdings Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2023-09-30 | $0.00B | $0.01B | 0.08 |
2023-06-30 | $0.00B | $0.01B | 0.15 |
2023-03-31 | $0.00B | $0.01B | 0.16 |
2022-12-31 | $0.00B | $0.02B | 0.20 |
2022-09-30 | $0.00B | $0.01B | 0.32 |
2022-06-30 | $0.00B | $0.01B | 0.25 |
2022-03-31 | $0.00B | $0.02B | 0.20 |
2021-12-31 | $0.00B | $0.02B | 0.20 |
2021-09-30 | $0.00B | $0.02B | 0.13 |
2021-06-30 | $0.00B | $0.02B | 0.11 |
2021-03-31 | $0.00B | $0.03B | 0.09 |
2020-12-31 | $0.00B | $0.02B | 0.14 |
2020-09-30 | $0.00B | $0.01B | 0.35 |
2020-06-30 | $0.00B | $0.01B | 0.27 |
2020-03-31 | $0.00B | $0.01B | 0.30 |
2019-12-31 | $0.00B | $0.01B | 0.67 |
2019-09-30 | $0.00B | $0.01B | 0.42 |
2019-06-30 | $0.00B | $0.01B | 0.30 |
2019-03-31 | $0.00B | $0.01B | 0.25 |
2018-12-31 | $0.00B | $0.02B | 0.14 |
2018-09-30 | $0.00B | $0.02B | 0.16 |
2018-06-30 | $0.03B | $-0.00B | -13.50 |
2018-03-31 | $0.01B | $0.01B | 0.60 |
2017-12-31 | $0.00B | $0.01B | 0.39 |
2017-09-30 | $0.00B | $0.01B | 0.31 |
2017-06-30 | $0.01B | $0.02B | 0.24 |
2017-03-31 | $0.01B | $0.02B | 0.21 |
2016-12-31 | $0.01B | $0.03B | 0.20 |
2016-09-30 | $0.01B | $0.03B | 0.20 |
2016-06-30 | $0.01B | $0.04B | 0.16 |
2016-03-31 | $0.01B | $0.04B | 0.15 |
2015-12-31 | $0.01B | $0.02B | 0.29 |
2015-09-30 | $0.01B | $0.02B | 0.41 |
2015-06-30 | $0.01B | $0.02B | 0.78 |
2015-03-31 | $0.02B | $0.01B | 1.63 |
2014-12-31 | $0.01B | $0.01B | 1.82 |
2014-09-30 | $0.01B | $0.01B | 0.50 |
2014-06-30 | $0.01B | $0.01B | 0.69 |
2014-03-31 | $0.00B | $0.01B | 0.43 |
2013-12-31 | $0.00B | $0.01B | 0.33 |
2013-09-30 | $0.00B | $0.02B | 0.23 |
2013-06-30 | $0.00B | $0.02B | 0.16 |
2013-03-31 | $0.03B | $-0.01B | -1.97 |
2012-12-31 | $0.02B | $-0.00B | -7.95 |
2012-09-30 | $0.01B | $0.01B | 2.37 |
2012-06-30 | $0.03B | $-0.01B | -5.23 |
2012-03-31 | $0.03B | $-0.01B | -3.53 |
2011-12-31 | $0.04B | $-0.03B | -1.18 |
2011-09-30 | $0.01B | $-0.00B | -8.80 |
2011-06-30 | $0.01B | $-0.00B | -2.52 |
2011-03-31 | $0.01B | $-0.00B | -3.64 |
2010-12-31 | $0.01B | $-0.00B | -6.06 |
2010-09-30 | $0.00B | $0.00B | -1.11 |
2010-06-30 | $0.00B | $0.00B | -1.28 |
2010-03-31 | $0.00B | $0.00B | -1.00 |
2009-12-31 | $0.00B | 0.00 | |
2009-09-30 | $0.00B | $0.00B | -1.00 |
2009-06-30 | $0.00B | $0.00B | -1.12 |
2009-03-31 | $0.00B | $0.00B | -1.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.001B | $0.000B |
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $204.664B | 26.43 |
Stryker (SYK) | United States | $141.745B | 33.12 |
Boston Scientific (BSX) | United States | $122.979B | 37.45 |
Medtronic (MDT) | Ireland | $115.565B | 17.20 |
EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
Haleon (HLN) | United Kingdom | $48.437B | 35.40 |
Lonza Group Ag (LZAGY) | Switzerland | $47.258B | 0.00 |
ResMed (RMD) | United States | $36.993B | 32.57 |
Koninklijke Philips (PHG) | Netherlands | $29.119B | 22.13 |
Terumo (TRUMY) | Japan | $27.757B | 39.20 |
Zimmer Biomet Holdings (ZBH) | United States | $21.878B | 13.77 |
Baxter (BAX) | United States | $20.540B | 13.93 |
Insulet (PODD) | United States | $16.399B | 68.99 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.775B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.205B | 30.50 |
Demant (WILYY) | Denmark | $9.197B | 0.00 |
BellRing Brands (BRBR) | United States | $7.646B | 32.33 |
Lantheus Holdings (LNTH) | United States | $7.464B | 17.92 |
ICU Medical (ICUI) | United States | $4.385B | 41.84 |
Haemonetics (HAE) | United States | $3.926B | 19.42 |
TG Therapeutics (TGTX) | United States | $3.854B | 40.80 |
Perrigo (PRGO) | Ireland | $3.848B | 12.16 |
GN Store Nord (GNNDY) | Denmark | $3.656B | 22.03 |
Prestige Consumer Healthcare (PBH) | United States | $3.651B | 18.19 |
Neogen (NEOG) | United States | $3.541B | 37.14 |
Envista Holdings (NVST) | United States | $3.248B | 17.33 |
QuidelOrtho (QDEL) | United States | $3.092B | 19.49 |
Agios Pharmaceuticals (AGIO) | United States | $2.584B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.305B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.294B | 38.50 |
LeMaitre Vascular (LMAT) | United States | $2.022B | 53.89 |
AdaptHealth (AHCO) | United States | $1.537B | 11.10 |
Warby Parker (WRBY) | United States | $1.510B | 0.00 |
InMode (INMD) | Israel | $1.433B | 9.12 |
AtriCure (ATRC) | United States | $1.329B | 0.00 |
Owens & Minor (OMI) | United States | $1.237B | 9.55 |
BioLife Solutions (BLFS) | United States | $1.175B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.157B | 0.00 |
Evolus (EOLS) | United States | $1.058B | 0.00 |
PetIQ (PETQ) | United States | $0.918B | 23.28 |
Phibro Animal Health (PAHC) | United States | $0.872B | 18.09 |
National Vision Holdings (EYE) | United States | $0.848B | 26.95 |
Cresco Labs (CRLBF) | United States | $0.830B | 0.00 |
Surmodics (SRDX) | United States | $0.563B | 119.51 |
Quanterix (QTRX) | United States | $0.498B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.472B | 14.23 |
ZimVie (ZIMV) | United States | $0.462B | 42.95 |
Valneva SE (VALN) | France | $0.438B | 0.00 |
Canopy Growth (CGC) | Canada | $0.418B | 0.00 |
Jin Medical (ZJYL) | China | $0.394B | 0.00 |
Cerus (CERS) | United States | $0.382B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.341B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.328B | 8.46 |
Aurora Cannabis (ACB) | Canada | $0.323B | 0.00 |
Biote (BTMD) | United States | $0.320B | 14.77 |
Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.288B | 30.96 |
Zynex (ZYXI) | United States | $0.253B | 44.28 |
Ayr Wellness (AYRWF) | United States | $0.241B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.234B | 15.56 |
Omeros (OMER) | United States | $0.226B | 0.00 |
MacroGenics (MGNX) | United States | $0.215B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.197B | 0.00 |
High Tide (HITI) | Canada | $0.176B | 73.00 |
FitLife Brands (FTLF) | United States | $0.150B | 20.26 |
Capricor Therapeutics (CAPR) | United States | $0.144B | 0.00 |
Brainsway (BWAY) | Israel | $0.141B | 168.80 |
TriSalus Life Sciences (TLSI) | United States | $0.137B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.119B | 0.00 |
Veru (VERU) | United States | $0.119B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
Fonar (FONR) | United States | $0.109B | 11.01 |
Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.80 |
InterCure (INCR) | Israel | $0.087B | 14.69 |
Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.075B | 0.00 |
Modular Medical (MODD) | United States | $0.074B | 0.00 |
Safety Shot (SHOT) | United States | $0.072B | 0.00 |
Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
MariMed (MRMD) | United States | $0.064B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.58 |
Exagen (XGN) | United States | $0.051B | 0.00 |
Bright Green (BGXX) | United States | $0.037B | 0.00 |
Apyx Medical (APYX) | United States | $0.037B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.037B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.019B | 0.00 |
GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
Agape ATP (ATPC) | $0.009B | 0.00 | |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Sharps Technology (STSS) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 21.14 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |